Cargando…
Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
Autores principales: | Yao, Wei, Cao, Qianqian, Luo, Shilin, He, Lujuan, Yang, Chun, Chen, Jiaxu, Qi, Qi, Hashimoto, Kenji, Zhang, Ji-chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095483/ https://www.ncbi.nlm.nih.gov/pubmed/34880451 http://dx.doi.org/10.1038/s41380-021-01417-2 |
Ejemplares similares
-
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
por: Yao, Wei, et al.
Publicado: (2021) -
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents
por: Yao, Wei, et al.
Publicado: (2021) -
A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
por: Hashimoto, Kenji
Publicado: (2012) -
PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine
por: Xue, Wenda, et al.
Publicado: (2016) -
Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
por: Zhang, Kai, et al.
Publicado: (2020)